NJ S3033 | 2016-2017 | Regular Session

Note: Carry Foward to future S2060

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 27 2017 - 25% progression, died in committee
Action: 2017-02-27 - Introduced in the Senate, Referred to Senate Commerce Committee
Pending: Senate Commerce Committee
Text: Latest bill text (Introduced) [HTML]

Summary

"Prescription Drug Consumer Transparency Act;" requires pharmacy benefits managers to disclose certain information to benefit plan purchasers and to establish toll-free telephone number for certain inquiries.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

"Prescription Drug Consumer Transparency Act;" requires pharmacy benefits managers to disclose certain information to benefit plan purchasers and to establish toll-free telephone number for certain inquiries.

Sponsors


History

DateChamberAction
2017-02-27SenateIntroduced in the Senate, Referred to Senate Commerce Committee

Same As/Similar To

S3033 (Carry Over) 2017-02-27 - Introduced in the Senate, Referred to Senate Commerce Committee
A4338 (Same As) 2017-02-15 - Assembly Floor Amendment Passed (Johnson)

Subjects


New Jersey State Sources


Bill Comments

feedback